Although blockchain faces regulatory hurdles and skepticism, its potential as a shared, yet secure ledger system to improve the pharmaceutical supply chain integrity and clinical trials is making it attractive for experimentation and investment by drugmakers.
The Philadelphia event from July 11-12 highlights the most compelling topics in healthcare from breaking down the data silos in cancer research, how to scale precision medicine, the reimbursement hurdles for genetic testing, AI applications and investment trends in oncology and precision medicine.
Munck Wilson Mandala Partner Greg Howison shared his perspective on some of the legal ramifications around AI, IP, connected devices and the data they generate, in response to emailed questions.
Not too long ago, dermatologist resident Dr. Michelle Longmire was crowdfunding on Medstartr for an app to improve care coordination for cancer patients. Now she’s the CEO of a mobile health startup Medable piloting a platform to help other mobile health app developers. The service helps them with HIPAA compliance and to enable them to […]